Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease
Dae-Hyuk Kwon MS
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorJong-Min Kim MD, PhD
Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital and Bundang Hospital, Seoul
Search for more papers by this authorSe-Hong Oh PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorHye-Jin Jeong MS
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorSung-Yeon Park MS
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorEung-Seok Oh MD
Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital and Bundang Hospital, Seoul
Search for more papers by this authorJe-Geun Chi MD, PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea
Search for more papers by this authorYoung-Bo Kim MD, PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorBeom S. Jeon MD, PhD
Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital and Bundang Hospital, Seoul
Search for more papers by this authorCorresponding Author
Zang-Hee Cho PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Neuroscience Research Institute, Gachon University of Medicine and Science, 1198 Kuwol-dong, Namdong-gu, Incheon 405-760, South KoreaSearch for more papers by this authorDae-Hyuk Kwon MS
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorJong-Min Kim MD, PhD
Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital and Bundang Hospital, Seoul
Search for more papers by this authorSe-Hong Oh PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorHye-Jin Jeong MS
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorSung-Yeon Park MS
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorEung-Seok Oh MD
Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital and Bundang Hospital, Seoul
Search for more papers by this authorJe-Geun Chi MD, PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea
Search for more papers by this authorYoung-Bo Kim MD, PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Search for more papers by this authorBeom S. Jeon MD, PhD
Department of Neurology, Seoul National University College of Medicine, Seoul National University Hospital and Bundang Hospital, Seoul
Search for more papers by this authorCorresponding Author
Zang-Hee Cho PhD
Neuroscience Research Institute, Gachon University of Medicine and Science, Incheon
Neuroscience Research Institute, Gachon University of Medicine and Science, 1198 Kuwol-dong, Namdong-gu, Incheon 405-760, South KoreaSearch for more papers by this authorAbstract
Objective:
To investigate anatomical changes in the substantia nigra (SN) of Parkinson disease (PD) patients with age-matched controls by using ultra-high field magnetic resonance imaging (MRI).
Methods:
We performed 7T MRI in 10 PD and 10 age-matched control subjects. Magnetic resonance images of the SN were obtained from a 3-dimensional (3D) T2*-weighted gradient echo sequence. Region of interest-based 3D shape analysis was performed to quantitatively compare images from the 2 groups.
Results:
The boundary between the SN and crus cerebri was not smooth in PD subjects. Undulation in the lateral surface of the SN appeared more intense in the side contralateral to that with the more severe symptoms, and more prominent at the rostral level of the SN than at the intermediate or caudal levels. In addition to the lateral surface, there was a striking difference in the dorsomedial aspects of the SN between PD and control subjects. In control subjects, a brighter signal region was observed along the dorsomedial surface of the lateral portion of SN, whereas in PD subjects, this region was observed as a dark region containing a hypointense signal in T2*-weighted images. The measurement of SN volumes, normalized to the intracranial volumes, showed higher values in PD subjects than in control subjects.
Interpretation:
This study demonstrates that 3D 7T MRI can definitively visualize anatomical alterations occurring in the SN of PD subjects. Further pathological studies are required to elucidate the nature of these anatomical alterations. Ann Neurol 2012;71:267–277
Supporting Information
Additional supporting information can be found in the online version of this article.
| Filename | Description |
|---|---|
| ANA_22592_sm_SuppInfo.doc116.5 KB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1 Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114( pt 5): 2283–2301.
- 2 Dexter DT, Wells FR, Agid F, et al. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987; 2: 1219–1220.
- 3 Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 1988; 74: 199–205.
- 4 Drayer B, Burger P, Darwin R, et al. MRI of brain iron. AJR Am J Roentgenol 1986; 147: 103–110.
- 5 Rutledge JN, Hilal SK, Silver AJ, et al. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987; 149: 365–379.
- 6 Bartzokis G, Aravagiri M, Oldendorf WH, et al. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 1993; 29: 459–464.
- 7 Graham JM, Paley MN, Grünewald RA, et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 2000; 123( pt 12): 2423–2431.
- 8 Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999; 210: 759–767.
- 9 Cho ZH, Min HK, Oh SH, et al. Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-Tesla magnetic resonance imaging. J Neurosurg 2010; 113: 639–647.
- 10 Oikawa H, Sasaki M, Tamakawa Y, et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002; 23: 1747–1756.
- 11 Cho ZH, Oh SH, Kim JM, et al. Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T MRI. Mov Disord 2011; 26: 713–718.
- 12 Cho ZH, Kim YB, Han JY, et al. New brain atlas-mapping the human brain in vivo with 7.0T MRI and comparison with postmortem histology: will these images change modern medicine? Int J Imaging Syst Technol 2008; 18: 2–8.
- 13 Chen Z, Johnston LA, Kwon DH, et al. An optimised framework for reconstructing and processing MR phase images. Neuroimage 2010; 49: 1289–1300.
- 14 Cho ZH, Han JY, Hwang SI, et al. Quantitative analysis of the hippocampus using images obtained from 7.0 T MRI. Neuroimage 2010; 49: 2134–2140.
- 15 Abosch A, Yacoub E, Ugurbil K, Harel N. An assessment of current brain targets for deep brain stimulation surgery with susceptibility-weighted imaging at 7 Tesla. Neurosurgery 2010; 67: 1745–1756.
- 16 Eapen M, Zald DH, Gatenby JC, et al. Using high-resolution MR imaging at 7T to evaluate the anatomy of the midbrain dopaminergic system. AJNR Am J Neuroradiol 2011; 32: 688–694.
- 17 Chung MK, Dalton KM, Shen L, et al. Weighted Fourier series representation and its application to quantifying the amount of gray matter. IEEE Trans Med Imaging 2007; 26: 566–581.
- 18
Chung MK,
Nacewicz BM,
Wang S, et al.
Amygdala surface modeling with weighted spherical harmonics. In:
T Dohl,
I Sakuma,
H Liao, editors.
The 4th international workshop on medical imaging and augmented reality (MIAR 2008).
Berlin, Germany:
Springer,
2008:
177–184.
10.1007/978-3-540-79982-5_20 Google Scholar
- 19 Eritaia J, Wood SJ, Stuart GW, et al. An optimized method for estimating intracranial volume from magnetic resonance images. Magn Reson Med 2000; 44: 973–977.
- 20 Lehéricy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994; 15: 929–937.
- 21 Malykhin NV, Bouchard TP, Ogilvie CJ, et al. Three-dimensional volumetric analysis and reconstruction of amygdala and hippocampal head, body and tail. Psychiatry Res 2007; 155: 155–165.
- 22 Sofic E, Paulus W, Jellinger K, et al. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991; 56: 978–982.
- 23 Hirsch EC, Brandel JP, Galle P, et al. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 1991; 56: 446–451.
- 24 Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 1992; 593: 343–346.
- 25 Griffiths PD, Dobson BR, Jones GR, Clarke DT. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 1999; 122( pt 4): 667–673.
- 26 Antonini A, Leenders KL, Meier D, et al. T2 relaxation time in patients with Parkinson's disease. Neurology 1993; 43: 697–700.
- 27 Gorell JM, Ordidge RJ, Brown GG, et al. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995; 45: 1138–1143.
- 28 Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999; 122( pt 8): 1421–1436.
- 29 Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999; 122( pt 8): 1437–1448.
- 30 Björklund A, Lindvall O. Dopamine-containing systems in the CNS. In: A Björklund, T Hökfelt, editors. Classical transmitters in the CNS, part I. Handbook of chemical neuroanatomy. Vol 2. Amsterdam, the Netherlands: Elsevier, 1984: 55–122.
- 31 Lewis DA, Sesack SR. Dopamine systems in the primate brain. In: FE Bloom, A Björklund, T Hökfelt, editors. The primate nervous system, part I. Handbook of chemical neuroanatomy. vol 13. Amsterdam, the Netherlands: Elsevier, 1997: 263–375.
- 32 Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30: 194–202.
- 33 Zecca L, Youdim MB, Riederer P, et al. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004; 5: 863–873.
- 34 Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 2006; 17: 5–17.
- 35 Fasano M, Bergamasco B, Lopiano L. Modifications of the iron-neuromelanin system in Parkinson's disease. J Neurochem 2006; 96: 909–916.
- 36 Jellinger KA, Kienzl E, Rumpelmaier G, et al. Iron and ferritin in substantia nigra in Parkinson's disease. Adv Neurol 1993; 60: 267–272.
- 37 Gerlach M, Double KL, Youdim MB, Riederer P. Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl 2006; (70): 133–142.
- 38 Sasaki M, Shibata E, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006; 17: 1215–1218.
- 39 Shibata E, Sasaki M, Tohyama K, et al. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 2008; 64: 401–406.
- 40 Adachi M, Hosoya T, Haku T, et al. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol 1999; 20: 1500–1506.
- 41 Hutchinson M, Raff U. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. AJNR Am J Neuroradiol 2000; 21: 697–701.
- 42 Manova ES, Habib CA, Boikov AS, et al. Characterizing the mesencephalon using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2009; 30: 569–574.
- 43 Menke RA, Jbabdi S, Miller KL, et al. Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease. Neuroimage 2010; 52: 1175–1180.
- 44 Duguid JR, De La Paz R, DeGroot J. Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986; 20: 744–747.
- 45 Stern MB, Braffman BH, Skolnick BE, et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes. Neurology 1989; 39: 1524–1526.
- 46 Huber SJ, Chakeres DW, Paulson GW, Khanna R. Magnetic resonance imaging in Parkinson's disease. Arch Neurol 1990; 47: 735–737.
- 47 Pujol J, Junqué C, Vendrell P, et al. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch Neurol 1992; 49: 1119–1122.
- 48 Doraiswamy PM, Shah SA, Husain MM, et al. Magnetic resonance evaluation of the midbrain in Parkinson's disease. Arch Neurol 1991; 48: 360.
- 49 Ryvlin P, Broussolle E, Piollet H, et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. Arch Neurol 1995; 52: 583–588.
- 50 Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999; 17: 213–222.
- 51 Massey LA, Yousry TA. Anatomy of the substantia nigra and subthalamic nucleus on MR imaging. Neuroimaging Clin N Am 2010; 20: 7–27.
- 52 Schoene WC. Degenerative diseases of the central nervous system. In: AL Davis, DM Robertson, editors. Textbook of neuropathology. Baltimore, MD: Williams & Wilkins, 1985: 788–823.
- 53 Dexter DT, Sian J, Jenner P, Marsden CD. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. Adv Neurol 1993; 60: 273–281.
- 54 Tamraz JC, Comair YG. Atlas of regional anatomy of the brain using MRI. Berlin, Germany: Springer, 2000.
Citing Literature
